Tag: 1 Cancer treatment

Browse exclusive Tags!

Vividion Initiates Phase I Trial for VVD-130850, an Oral STAT3 Inhibitor for Advanced Solid and Hematologic Tumors, US

Vividion's Phase I trial for VVD-130850, an oral STAT3 inhibitor for advanced tumors, marks a major breakthrough in cancer treatment.

Indian Cancer Center Cultivates Medicinal Plants for Breakthrough Cancer Treatment

Indian Cancer Center conducts groundbreaking research on over 500 medicinal plants for potential cancer treatment. Exciting breakthroughs with ashwagandha have inspired a new facility in Mumbai. Discover the future of traditional medicine in combating cancer.

Potential Breakthrough in Cancer Treatment: Scientists Modify Compound for Safer and More Effective Therapy, Philippines

Scientists from the University of the Philippines have modified a compound to create a novel class of anticancer agents showing promising results in the treatment of colon, lung, and breast cancer. The modified compounds are safer and more effective than current drugs, offering hope for improved cancer treatment.

Iran Develops New Recombinant Medicines for Cancer Treatment

Iran develops groundbreaking recombinant drugs for cancer treatment, offering new hope for patients battling lung, liver, and skin cancers.

Popular

Potential Breakthrough in Cancer Treatment: Scientists Modify Compound for Safer and More Effective Therapy, Philippines

Scientists from the University of the Philippines have modified a compound to create a novel class of anticancer agents showing promising results in the treatment of colon, lung, and breast cancer. The modified compounds are safer and more effective than current drugs, offering hope for improved cancer treatment.

Indian Cancer Center Cultivates Medicinal Plants for Breakthrough Cancer Treatment

Indian Cancer Center conducts groundbreaking research on over 500 medicinal plants for potential cancer treatment. Exciting breakthroughs with ashwagandha have inspired a new facility in Mumbai. Discover the future of traditional medicine in combating cancer.

Vividion Initiates Phase I Trial for VVD-130850, an Oral STAT3 Inhibitor for Advanced Solid and Hematologic Tumors, US

Vividion's Phase I trial for VVD-130850, an oral STAT3 inhibitor for advanced tumors, marks a major breakthrough in cancer treatment.

Subscribe

spot_imgspot_img